117 related articles for article (PubMed ID: 24398995)
1. Valproic acid substantially downregulated genes folr1, IGF2R, RGS2, COL6A3, EDNRB, KLF6, and pax-3, N-acetylcysteine alleviated most of the induced gene alterations in chicken embryo model.
Hsieh CL; Chen KC; Ding CY; Tsai WJ; Wu JF; Peng CC
Rom J Morphol Embryol; 2013; 54(4):993-1004. PubMed ID: 24398995
[TBL] [Abstract][Full Text] [Related]
2. Multiple point action mechanism of valproic acid-teratogenicity alleviated by folic acid, vitamin C, and N-acetylcysteine in chicken embryo model.
Hsieh CL; Wang HE; Tsai WJ; Peng CC; Peng RY
Toxicology; 2012 Jan; 291(1-3):32-42. PubMed ID: 22051200
[TBL] [Abstract][Full Text] [Related]
3. Valproic acid-induced deregulation in vitro of genes associated in vivo with neural tube defects.
Jergil M; Kultima K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2009 Mar; 108(1):132-48. PubMed ID: 19136453
[TBL] [Abstract][Full Text] [Related]
4. Valproic acid-induced somite teratogenesis in the chick embryo: relationship with Pax-1 gene expression.
Barnes GL; Mariani BD; Tuan RS
Teratology; 1996 Aug; 54(2):93-102. PubMed ID: 8948545
[TBL] [Abstract][Full Text] [Related]
5. Short-time gene expression response to valproic acid and valproic acid analogs in mouse embryonic stem cells.
Jergil M; Forsberg M; Salter H; Stockling K; Gustafson AL; Dencker L; Stigson M
Toxicol Sci; 2011 Jun; 121(2):328-42. PubMed ID: 21427059
[TBL] [Abstract][Full Text] [Related]
6. Altered signal transduction in Folr1-/- mouse embryo fibroblasts.
Warner DR; Webb CL; Greene RM; Pisano MM
Cell Biol Int; 2011 Dec; 35(12):1253-9. PubMed ID: 21649587
[TBL] [Abstract][Full Text] [Related]
7. Folate receptors and neural tube closure.
Saitsu H
Congenit Anom (Kyoto); 2017 Sep; 57(5):130-133. PubMed ID: 28244241
[TBL] [Abstract][Full Text] [Related]
8. Exencephaly induction by valproic acid in the genetic polydactyly/arhinencephaly mouse, Pdn/Pdn.
Maekawa M; Ohta K; Katagiri R; Ueta E; Naruse I
Congenit Anom (Kyoto); 2005 Dec; 45(4):132-6. PubMed ID: 16359493
[TBL] [Abstract][Full Text] [Related]
9. Identification of early-responsive genes correlated to valproic acid-induced neural tube defects in mice.
Okada A; Kushima K; Aoki Y; Bialer M; Fujiwara M
Birth Defects Res A Clin Mol Teratol; 2005 Apr; 73(4):229-38. PubMed ID: 15799026
[TBL] [Abstract][Full Text] [Related]
10. Teratogenic effects mediated by inhibition of histone deacetylases: evidence from quantitative structure activity relationships of 20 valproic acid derivatives.
Eikel D; Lampen A; Nau H
Chem Res Toxicol; 2006 Feb; 19(2):272-8. PubMed ID: 16485903
[TBL] [Abstract][Full Text] [Related]
11. Valproic acid teratogenicity: a toxicogenomics approach.
Kultima K; Nyström AM; Scholz B; Gustafson AL; Dencker L; Stigson M
Environ Health Perspect; 2004 Aug; 112(12):1225-35. PubMed ID: 15345369
[TBL] [Abstract][Full Text] [Related]
12. An in ovo chicken model to study the systemic and localized teratogenic effects of valproic acid.
Whitsel AI; Johnson CB; Forehand CJ
Teratology; 2002 Oct; 66(4):153-63. PubMed ID: 12353211
[TBL] [Abstract][Full Text] [Related]
13. Folic acid and pantothenic acid protection against valproic acid-induced neural tube defects in CD-1 mice.
Dawson JE; Raymond AM; Winn LM
Toxicol Appl Pharmacol; 2006 Mar; 211(2):124-32. PubMed ID: 16112698
[TBL] [Abstract][Full Text] [Related]
14. Homocysteine causes disruptions in spinal cord morphology and changes the expression of Pax 1/9 and Sox 9 gene products in the axial mesenchyme.
Kobus K; Ammar D; Nazari EM; Müller YM
Birth Defects Res A Clin Mol Teratol; 2013 Jun; 97(6):386-97. PubMed ID: 23716459
[TBL] [Abstract][Full Text] [Related]
15. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
16. VPA-induced neural tube defects in mice. I. Altered metabolism of sulfur amino acids and glutathione.
Hishida R; Nau H
Teratog Carcinog Mutagen; 1998; 18(2):49-61. PubMed ID: 9704382
[TBL] [Abstract][Full Text] [Related]
17. Valproic acid in pregnancy: how much are we endangering the embryo and fetus?
Ornoy A
Reprod Toxicol; 2009 Jul; 28(1):1-10. PubMed ID: 19490988
[TBL] [Abstract][Full Text] [Related]
18. Novel targets for valproic acid: up-regulation of melatonin receptors and neurotrophic factors in C6 glioma cells.
Castro LM; Gallant M; Niles LP
J Neurochem; 2005 Dec; 95(5):1227-36. PubMed ID: 16313512
[TBL] [Abstract][Full Text] [Related]
19. Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons.
Kanai H; Sawa A; Chen RW; Leeds P; Chuang DM
Pharmacogenomics J; 2004; 4(5):336-44. PubMed ID: 15289798
[TBL] [Abstract][Full Text] [Related]
20. Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
Fukuchi M; Nii T; Ishimaru N; Minamino A; Hara D; Takasaki I; Tabuchi A; Tsuda M
Neurosci Res; 2009 Sep; 65(1):35-43. PubMed ID: 19463867
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
